Munich OncoTrack

Gemeinsam mit dem DKTK bietet das CCC München seinen forschenden jungen Ärzt*innen und Nachwuchswissenschaftler*innen, den sog. Fellows, seit 2019 den Munich OncoTrack innerhalb der DKTK School of Oncology an. In ausgewählten Modulen können die Fellows für eine Hospitation in für sie interessante, klinische oder wissenschaftliche Abteilungen des eigenen Klinikums oder des jeweiligen Partnerklinikums wechseln (LMU Klinikum und Klinikum rechts der Isar). In dieser Rotation erhalten die Fellows über drei Jahre (mit 3-4 Tagen pro Jahr) gezielt Einblicke in Bereiche jenseits ihres eigenen onkologischen Fachbereichs.


Impressions of the Munich OncoTrack


Within the Munic OncoTrack rotation I spent 3 fascinating days at the Department of Radiotherapy and Radiation Oncology at the LMU Klinikum, Campus Großhadern. The rotation was the perfect opportunity to gain insight into the planning and application of radiotherapy. I was particularly impressed by stereotactic radiotherapy, brachytherapy and the revolutionary technology of the MR Linac, which tracks tumors via MRI in real-time for stereotactic radiotherapy with the highest possible precision. Furthermore I was able to increase my knowledge in the out- and in-patient management of radiation side effects, which will be useful for my clinical work. I would like to thank the whole team of the Department of Radiotherapy and Radiation Oncology at the LMU Klinikum for the warm welcome and the kind mentoring!



Dr. med. Veronika Dill (Klinik und Poliklinik für Innere Medizin III Hämatologie und Onkologie, MRI) in der Klinik und Poliklinik für Strahlentherapie und Radioonkologie des LMU Klinikums

Dezember 2020 © V. Dill

2020 - Radiologie Kunz_Marschner

Dr. med. Sebastian Marschner (Klinik und Poliklinik für Strahlentherapie und Radioonkologie, LMU Klinikum) mit PD Dr. Wolfgang Kunz in der Klinik und Poliklinik für Radiologie des LMU Klinikums

November 2020 © S. Marschner

The clinical 3-day Munich OncoTrack rotation at the Department of Radiology at the LMU Munich was a great opportunity to learn more about oncological diagnostics. Starting with CT imaging, I was able to get to know the different diagnostic and evaluation programs that are used in diagnostics but also in research. I learned how oncological reports are made for various diagnosis, which things have to be considered and which pitfalls exist. In the PET-CT department, I got a lot of insight into the process from tracer injection to the final written report and the advantages and disadvantages of PET-CT imaging. Overall, I was able to improve my diagnostic skills and gain further input for research topics and collaborations with the department of radiology. I can highly recommend participating in the Munich OncoTrack Program!

The clinical rotation Munich OncoTrack at Klinikum rechts der Isar MRI in Sept./Oct. 2020 enabled me to improve my clinical knowledge in the field of oncology. I had the chance to participate in various clinical divisions from the outpatient clinic to the hospital ward which deals with autologous and allogeneic stem cell transplant patients. The highlight of the rotation was my participation in the molecular tumor board MTB, discussing clinical-pathological data and molecular findings of selected cancer patients with an interdisciplinary team of physicians. I can highly recommend applying for the Munich OncoTrack, to broaden one's horizon and to gain new research collaboration partners for multimodal treatment approaches.


Dr. med. Lukas Käsmann (Klinik und Poliklinik für Strahlentherapie und Radioonkologie, LMU Klinikum) in der Klinik und Poliklinik für Innere Medizin III Hämatologie und Onkologie (MRI)

Oktober 2020 © L. Käsmann


M. Sc. Johannes Hildebrand (Medizinische Klinik und Poliklinik III, LMU Klinikum) mit PD Dr. Melissa Schlitter am Institut für Pathologie der TUM

September 2020 © J. Hildebrand

The DKTK 3-day research rotation Munich OncoTrack at the Institute of Pathology TUM gave me valuable insights in the state-of-the-art methods which are used in daily routine as well as in research projects of pathologists. Starting with isolated patients´ organs, I learned the involved steps from macroscopic sectioning to frozen section procedure or formalin fixation, followed by histologic diagnosis as well as further molecular analysis via next-generation-sequencing of isolated DNA and RNA from tumor areas. My research project will benefit from the acquired knowledge as well as the interdisciplinary communication which might lead to novel collaborations.